Early Health Economic Modelling – Optimizing Development for Medical Device Developers?; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”

Document Type : Commentary


Health Information and Quality Authority, Dublin, Ireland


This commentary considers the positive and negative consequences of early economic modelling and explores potential future directions. Early economic modelling offers device manufacturers an opportunity to assess the potential value of an innovation at an early stage of development. Early modelling can direct resources into potentially viable technologies and reduce investment in technologies with limited prospect of value. However, it is unclear whether early modelling is sufficiently specific to identify innovations with low value. It may be that early modelling is more useful for directing data gathering to reduce decision uncertainty. Early modelling is of primary benefit to the manufacturer and may have both positive and negative consequences for reimbursement processes that should be considered.


Main Subjects

  1. Grutters JPC, Govers T, Nijboer J, Tummers M, van der Wilt GJ, Rovers MM. Problems and promises of health technologies: the role of early health economic modeling. Int J Health Policy Manag. 2019;8(10):575-582. doi:10.15171/ijhpm.2019.36
  2. Ijzerman MJ, Steuten LM. Early assessment of medical technologies to inform product development and market access: a review of methods and applications. Appl Health Econ Health Policy. 2011;9(5):331-347. doi:10.2165/11593380-000000000-00000
  3. Callea G, Armeni P, Marsilio M, Jommi C, Tarricone R. The impact of HTA and procurement practices on the selection and prices of medical devices. Soc Sci Med. 2017;174:89-95. doi:10.1016/j.socscimed.2016.11.038
  4. Cao Q, Postmus D, Hillege HL, Buskens E. Probability elicitation to inform early health economic evaluations of new medical technologies: a case study in heart failure disease management. Value Health. 2013;16(4):529-535. doi:10.1016/j.jval.2013.02.008
  5. Girling A, Young T, Brown C, Lilford R. Early-stage valuation of medical devices: the role of developmental uncertainty. Value Health. 2010;13(5):585-591. doi:10.1111/j.1524-4733.2010.00726.x
  6. Markiewicz K, van Til JA, MJ IJ. Medical devices early assessment methods: systematic literature review. Int J Technol Assess Health Care. 2014;30(2):137-146. doi:10.1017/s0266462314000026
  7. IJzerman MJ, Koffijberg H, Fenwick E, Krahn M. Emerging use of early health technology assessment in medical product development: a scoping review of the literature. Pharmacoeconomics. 2017;35(7):727-740. doi:10.1007/s40273-017-0509-1
Volume 9, Issue 9
September 2020
Pages 403-405
  • Receive Date: 25 September 2019
  • Revise Date: 10 December 2019
  • Accept Date: 11 December 2019
  • First Publish Date: 01 September 2020